The company reaffirmed its $35M-$45M adjusted EBITDA guidance while outlining a revenue outlook for the fiscal year.
Skin Health Systems Inc. (SKIN) set a FY2026 revenue target of $280M to $295M during its Q1 2026 earnings call. The company maintained its adjusted EBITDA guidance at $35M to $45M, unchanged from prior expectations.
Management highlighted a strategic rebranding from SkinHealth to Skin Health Systems, signaling a shift in operational focus. The outlook reflects confidence in growth despite broader market uncertainties.
No immediate market reaction was disclosed in the call summary.